Mahasweta Gooptu, MD discusses results from the NMDP-sponsored access expansion Study
Dana-Farber
December 22, 2025
Phase 2 Study of post transplant cyclophosphamide-based graft versus host disease prophlaxis after HLA-mismatched unrelated donor transplantation and reduced intensity conditioning